Category: Intellectual property
-
Moderna, Merck Partner on Personal Cancer Vaccines
29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 million, and the chance to earn further payments to develop cancer treatments combining Moderna’s technology with an…
-
Celgene, Medical Centers to Partner on Cancer Therapies
Biopharmaceutical company Celgene Corp. and a consortium of four medical research institutes are collaborating on new diagnostics and treatments for cancer.
-
Patent Given for Non-Invasive Spinal Stimulation Technology
2 June 2016. A New York neuroscientist who invented a device for stimulating the spinal cord from outside the body to relieve muscle spasticity and paralysis, received a patent for his technology. U.S. Patent and Trademark Office awarded patent number 9,283,391 to physical therapy professor Zaghloul Ahmed at College of Staten Island, a division of…
-
Patent Awarded for Skin Stem Cell Regeneration Methods
24 May 2016. Two faculty members at Worcester Polytechnic Institute in Massachusetts received a patent for techniques that make regeneration of human tissue with adult stem cells more direct and productive. Patent number 9,290,740 was issued by the U.S. Patent and Trademark Office in March 2016 to biomedical engineering professor Raymond Page and biotechnology professor…
-
Start-Up Licenses Genetics Technology for HIV Diagnostics
19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed. Aldatu Biosciences is the creation of pathologist Iain MacLeod and geneticist David Raiser that…
-
ReWalk, Wyss Institute Developing Soft Exoskeleton Robot
17 May 2016. A robotics company is licensing technology from a bioengineering lab at Harvard University to develop systems for people needing help with mobility, such as those with multiple sclerosis or suffering a stroke. Financial aspects of the deal between ReWalk Robotics Ltd. in Yokneam Ilit, Israel and the Wyss Institute for Biologically Inspired…
-
Biogen, UPenn Partner in $2B Gene Therapy Research Deal
16 May 2016. The biotechnology company Biogen is collaborating with University of Pennsylvania’s medical school on research into gene therapies and editing, with payments to the university totaling as much as $2 billion. The partnership will fund research in the labs of University of Pennsylvania medical professors James Wilson and Jean Bennett, who study gene…
-
Collaborations Study Microbiome in Cancer, Metabolic Disease
12 May 2016. The biopharmaceutical company Seres Therapeutics is sponsoring research into the role of gut microbes in cancer and metabolic disorders, at Memorial Sloan Kettering Cancer Center and University of Pennsylvania. Financial ]aspects of the agreements between Seres, in Cambridge, Massachusetts, and Memorial Sloan Kettering and Penn were not disclosed. Seres Therapeutics discovers and…
-
Patent Granted for RNA Transcription Technology
3 May 2016. A technology that blocks RNA molecules from activating chemicals in the body suppressing the working of genes to treat or prevent disease received a U.S. patent. The Patent and Trademark Office awarded patent number 9,328,346 to five inventors and assigned the patent to the parent company of Massachusetts General Hospital in Boston.…
-
Start-Up Licensing Biologic Delivery Nanoparticles
8 April 2016. A start-up enterprise is licensing research from a university pharmacy lab that harnesses nanoscale particles to boost the performance of biologic therapies. Financial details of the agreement between Zoetic Pharmaceuticals in Amherst, New York and University at Buffalo were not disclosed. Biologic therapies are synthetic proteins derived from living systems, such as…